Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay D Naik

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Clinical Pathology|October 21, 2011
Mucinous tumours of the ovaryJay D Naik, Jenny Seligmann, Timothy J Perren
BMJ (Clinical Research Ed.)|December 21, 2010
Febrile neutropeniaJay D Naik, Suren R K Sathiyaseelan, Naveen S Vasudev
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2011
Immune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy?Jay D Naik, Christopher J Twelves, Peter J Selby, et al.
BJU International|August 24, 2006
High-dose chemotherapy with haematopoietic stem-cell support in patients with poor prognosis, relapsed or refractory germ cell tumoursLoaie M El-Helw, Jay D Naik, John D Chester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorinIvo M Hennig, Jay D Naik, Sarah Brown, et al.
British Journal of Cancer|April 24, 2024
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United KingdomDaire Hanna, Sophie Merrick, Aruni Ghose, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Clinical Pathology|October 21, 2011
Mucinous tumours of the ovaryJay D Naik, Jenny Seligmann, Timothy J Perren
BMJ (Clinical Research Ed.)|December 21, 2010
Febrile neutropeniaJay D Naik, Suren R K Sathiyaseelan, Naveen S Vasudev
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2011
Immune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy?Jay D Naik, Christopher J Twelves, Peter J Selby, et al.
BJU International|August 24, 2006
High-dose chemotherapy with haematopoietic stem-cell support in patients with poor prognosis, relapsed or refractory germ cell tumoursLoaie M El-Helw, Jay D Naik, John D Chester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorinIvo M Hennig, Jay D Naik, Sarah Brown, et al.
British Journal of Cancer|April 24, 2024
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United KingdomDaire Hanna, Sophie Merrick, Aruni Ghose, et al.
Pageof 1